Most people don't have the time to thoroughly research cannabis stocks, nor the experience to know when to buy or sell - this is where CST comes in.
We give everyday traders the opportunity to look over the shoulder of an equities analyst with a passion for the cannabis sector.
Members of CST get daily analysis and access to a model portfolio so they can review cannabis investments like a pro.
Leading The Way
Michael Vodicka is a globally syndicated equity analyst with more than 20 years of experience in trading and investing. His research has been featured in some of the industry’s most respected publications.
He has been investing and leading investors in the cannabis sector since 2013. Now, Mr. Vodicka brings his expertise and guidance to the members of Cannabis Stock Trades.
It’s one of Wall Street’s best-kept secrets – a studied market anomaly that helps investors ride a move after a company reports an earnings surprise. And right now looks like a great time to apply this strategy to the cannabis sector after two of the most exciting cannabis stocks just crushed fourth-quarter expectations.
For investors who love getting a good deal, this is an excellent time to take a fresh look at cannabis stocks.
After an incredible 12-month run higher from March of 2020 to February of 2021, cannabis stocks have entered a bear market – defined as a 20% or more decline from the 52-week high.
The Advisors Shares Pure U.S. Cannabis ETF (MSOS) is down 21% from the 52-week high in mid-February. Take a look at the 6-month chart below – you can see the all-time high from February and the recent decline. Continue “Cannabis Stocks on Sale after 20% Decline”